Poly(lactide‐co‐glycolide) (PLA50GA50) is a biodegradable and biocompatible polymer. It offers tremendous potential as a basis for drug delivery, either as drug delivery system alone or in conjugate with a medical device. The PLA50GA50 is the material of choice for relatively shorter‐duration applications, while the homopolymer PLA (poly‐L‐lactide) and PGA (polyglycolide) are preferred for longer term delivery of drugs. This paper discusses the degradation properties of poly(lactide‐co‐glycolide) (PLA50GA50) at inherent viscosity of 0.89 dL/g as preliminary studies for anticancer agent delivery.

This content is only available via PDF.
You do not currently have access to this content.